Notice to Extend Application Due Date for RFA-FD-20-027 "Integrated Pathogen Reduction Technologies for whole blood and blood components for transfusion (R01) Clinical Trial Not Allowed"

Notice Number: NOT-FD-20-026

Key Dates
Release Date: April 28, 2020

Related Announcements
RFA-FD-20-027

Issued by
FOOD AND DRUG ADMINISTRATION (FDA)

Purpose

This Notice is to extend the Application Due Date for RFA-FD-20-027 titled "Integrated Pathogen Reduction Technologies for whole blood and blood components for transfusion (R01) Clinical Trial Not Allowed"

New Application Due Date(s)

May 26, 2020, by 11:59 PM Eastern Time

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the applications during the submission process by the due date.

Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date.

Late applications will not be acceptable for this FOA.

Inquiries

Please direct all inquiries to:

Gordana Zuber
Grants Management Specialist
Office of Acquisitions and Grants Services
Tel: 301-348-1747
Email: gordana.zuber@fda.hhs.gov